Some new drugs aren't actually 'new': Pharmaceutical companies exploit patents and raise prices

Pharmaceutical innovation saves lives. But not every "new" drug is truly new.

Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation

By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.
Middle East Eye

Israel’s genocide in Gaza: Whatever happened to South Africa’s case at the ICJ?

Prevent genocidal acts: On 26 January 2024, the ICJ said that the right of Palestinians in Gaza to be protected from genocide ...
Daily Trojan

International students voice concerns under recent US government decisions

An international student at USC who requested anonymity for fear of this statement being used against them and who is a member of USC’s International Student Assembly, described how visa complications ...
96.5 KPEL

Louisiana Breaks CVS Pharmacy Monopoly for State Workers in Historic 2026 Deal

Louisiana lawmakers approved emergency contracts splitting pharmacy benefits between CVS and Natchitoches-based Liviniti, ...
National Law Review

The White House’s H-1B Proclamation - What Employers and Workers Need to Know About the New $100,000 Fee

In a rapidly evolving situation broadly impacting the business immigration community, the White House issued ...
Hawai‘i Public Radio

University of Hawaiʻi works to get a clearer picture of federal funding cuts

University of Hawaiʻi administrators hope to learn more this week about how deep budget cuts will be as a result of a U.S.